Leif Bostad

3.5k total citations
87 papers, 2.5k citations indexed

About

Leif Bostad is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Leif Bostad has authored 87 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 21 papers in Nephrology. Recurrent topics in Leif Bostad's work include Renal cell carcinoma treatment (20 papers), Renal Diseases and Glomerulopathies (19 papers) and Vasculitis and related conditions (12 papers). Leif Bostad is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Renal Diseases and Glomerulopathies (19 papers) and Vasculitis and related conditions (12 papers). Leif Bostad collaborates with scholars based in Norway, United States and Uganda. Leif Bostad's co-authors include Einar Svarstad, Camilla Tøndel, Bjørn Egil Vikse, Asle Hirth, Bjarne M. Iversen, P. G. Burhol, Christian Beisland, Knut Aasarød, Bjørn Straume and Bjørn Bernersen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Cancer.

In The Last Decade

Leif Bostad

86 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leif Bostad Norway 24 821 662 575 487 477 87 2.5k
Xinping Tian China 27 699 0.9× 159 0.2× 294 0.5× 268 0.6× 292 0.6× 214 2.8k
Nichola Cooper United Kingdom 33 896 1.1× 167 0.3× 881 1.5× 600 1.2× 260 0.5× 141 7.2k
Véronique Le Guern France 29 996 1.2× 910 1.4× 483 0.8× 597 1.2× 249 0.5× 111 3.4k
B. Mougenot France 29 547 0.7× 209 0.3× 238 0.4× 1.2k 2.5× 1.0k 2.2× 67 3.0k
Regina Tardanico Italy 25 973 1.2× 239 0.4× 369 0.6× 263 0.5× 652 1.4× 76 2.1k
E Pettersson Sweden 23 1.2k 1.4× 416 0.6× 314 0.5× 710 1.5× 490 1.0× 57 2.7k
Sylvain Audia France 28 518 0.6× 241 0.4× 248 0.4× 126 0.3× 201 0.4× 127 2.6k
Pieter van Paassen Netherlands 37 3.1k 3.8× 942 1.4× 419 0.7× 1.2k 2.4× 680 1.4× 113 4.8k
Vicente Rodríguez‐Valverde Spain 26 1.2k 1.4× 185 0.3× 421 0.7× 327 0.7× 223 0.5× 67 3.2k
Naoki Sawa Japan 25 523 0.6× 148 0.2× 388 0.7× 893 1.8× 525 1.1× 264 2.2k

Countries citing papers authored by Leif Bostad

Since Specialization
Citations

This map shows the geographic impact of Leif Bostad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Bostad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Bostad more than expected).

Fields of papers citing papers by Leif Bostad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Bostad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Bostad. The network helps show where Leif Bostad may publish in the future.

Co-authorship network of co-authors of Leif Bostad

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Bostad. A scholar is included among the top collaborators of Leif Bostad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Bostad. Leif Bostad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bostad, Leif, et al.. (2024). The Prognostic Value of Human Papillomavirus Status in Penile Cancer: Outcomes From a Norwegian Cohort Study. Clinical Genitourinary Cancer. 22(5). 102127–102127. 1 indexed citations
2.
Bjørneklett, Rune, et al.. (2023). Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes. Clinical Kidney Journal. 16(12). 2514–2522. 7 indexed citations
3.
Bjørneklett, Rune, et al.. (2022). Utilizing the MEST score for prognostic staging in IgA nephropathy. BMC Nephrology. 23(1). 26–26. 17 indexed citations
4.
Hjelle, Karin M., et al.. (2021). The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 144. 155586–155586. 3 indexed citations
5.
6.
Hjelle, Karin M., et al.. (2013). Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology. 47(6). 462–471. 16 indexed citations
7.
Beisland, Christian, Elisabeth Grov Beisland, Karin M. Hjelle, et al.. (2013). Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology. 48(1). 52–64. 12 indexed citations
8.
Svarstad, Einar, et al.. (2012). En mann i 50-årene med feber, hoste og anuri. Tidsskrift for Den norske legeforening. 132(14). 1621–1624.
9.
Tøndel, Camilla, Leif Bostad, Kristin Kampevold Larsen, et al.. (2012). Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease. Journal of the American Society of Nephrology. 24(1). 137–148. 182 indexed citations
10.
Bostad, Leif, et al.. (2011). Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. Nephrology Dialysis Transplantation. 27(4). 1485–1491. 23 indexed citations
11.
Vikse, Bjørn Egil, Stein Hallan, Leif Bostad, T. Leivestad, & Bjarne M. Iversen. (2010). Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrology Dialysis Transplantation. 25(10). 3289–3296. 37 indexed citations
12.
Beisland, Christian, Karin M. Hjelle, Lars A. R. Reisæter, & Leif Bostad. (2009). Observation Should be Considered as an Alternative in Management of Renal Masses in Older and Comorbid Patients. European Urology. 55(6). 1419–1429. 67 indexed citations
13.
Bjørneklett, Rune, Bjørn Egil Vikse, Einar Svarstad, et al.. (2007). Long-Term Risk of Cancer in Membranous Nephropathy Patients. American Journal of Kidney Diseases. 50(3). 396–403. 65 indexed citations
14.
Vikse, Bjørn Egil, Lorentz M. Irgens, Leif Bostad, & Bjarne M. Iversen. (2006). Adverse Perinatal Outcome and Later Kidney Biopsy in the Mother. Journal of the American Society of Nephrology. 17(3). 837–845. 60 indexed citations
15.
Svarstad, Einar, et al.. (2005). Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabrys disease. Clinical Nephrology. 63(5). 394–401. 9 indexed citations
16.
Hausken, Trygve, et al.. (2004). Co-occurrence of Epstein-Barr Virus Infection and Ascites in Sarcoidosis. Scandinavian Journal of Infectious Diseases. 36(3). 232–234. 1 indexed citations
17.
Sagen, Jørn V., Leif Bostad, Pål R. Njølstad, & Oddmund Sövik. (2003). Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1β (HNF-1β) mutation carriers. Kidney International. 64(3). 793–800. 20 indexed citations
18.
Viste, Asgaut, et al.. (2003). Effects of the endothelin-1 receptor antagonist tezosentan on renal blood flow and diuresis during prolonged increased intra-abdominal pressure. Journal of Surgical Research. 115(1). 33–40. 2 indexed citations
19.
Aasarød, Knut, B. M. Iversen, Jens Hammerstrøm, et al.. (2000). Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrology Dialysis Transplantation. 15(5). 611–618. 120 indexed citations
20.
Norum, Jan, et al.. (1991). Correspondence. Acta Oncologica. 30(8). 987–988. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinping Tian Breakdown of academic impact, for papers by Nichola Cooper Breakdown of academic impact, for papers by Véronique Le Guern Breakdown of academic impact, for papers by B. Mougenot Breakdown of academic impact, for papers by Regina Tardanico Breakdown of academic impact, for papers by E Pettersson Breakdown of academic impact, for papers by Sylvain Audia Breakdown of academic impact, for papers by Pieter van Paassen Breakdown of academic impact, for papers by Vicente Rodríguez‐Valverde Breakdown of academic impact, for papers by Naoki Sawa
Rankless by CCL
2026